SCHEMBL5814006

SCHEMBL5814006

COc1ccc(CNC(=O)N2CCC2OC(c2ccccc2Cl)c2ccccc2Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.48
GLA P06280 1/20 0.47
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
PKM P14618 1/20 0.44
CASP3 P42574 1/20 0.44
ALDH1A1 P00352 3/20 0.43
TSHR P16473 2/20 0.43
CXCR4 P61073 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
IDO1 P14902 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRL1 P41146 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5814013 0.88 GLA (0.44) HRH3GLAPOLBMAPTPKM
SCHEMBL5816771 0.84 HPGD (0.48) MAPTPKMCASP3ALDH1A1TSHR
SCHEMBL5811091 0.79 RAB9A (0.46) HRH3POLBMAPTCASP3TSHR
SCHEMBL5821899 0.77 FABP3 (0.43) POLBMAPTALDH1A1CYP3A4CYP2C19
SCHEMBL5814015 0.77 GLA (0.46) HRH3GLAPOLBMAPTPKM
SCHEMBL5816782 0.74 TACR1 (0.45) MAPTPKMALDH1A1TSHRCYP3A4
SCHEMBL5815061 0.72 CNR1 (0.38) POLBMEN1KMT2A
SCHEMBL5811095 0.69 RAB9A (0.44) HRH3POLBMAPTCASP3TSHR
SCHEMBL30422304 0.67 HRH3 (0.45) HRH3GLAPKMCASP3ALDH1A1
SCHEMBL24011378 0.67 SMN1; SMN2 (0.58) HRH3POLBMAPTPKMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620395-A1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDERS VERNALIS RESEARCH LIMITED (GB) 2006-02-01 EP disclosed
WO-2004096763-A1 AZETIDINECARBOXAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CB1 RECEPTOR MEDIATED DISORDERS VERNALIS RESEARCH LIMITED (GB) 2004-11-11 WO disclosed